Valuation — not yet established
No valuation for Agilvax is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($4.2M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Agilvax
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2018 | Seed Round | $3.0M | ▮ | ▮ |
| Mar 2017 | Accelerator/Incubator | — | ▮ | ▮ |
| Jun 2014 | Seed Round | $1.1M | ▮ | ▮ |
How Agilvax's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Agilvax, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Agilvax raised?
- Agilvax has raised $4.2M in total funding across 3 recorded rounds.
- When did Agilvax last raise?
- Agilvax last raised in Apr 2018 (Seed Round), raising $3.0M.